A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LOH / late-onset hypogonadism

[Related PubMed/MEDLINE]
Total Number of Papers: 216
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LOH  (>> Co-occurring Abbreviation)
Long Form:   late-onset hypogonadism
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Critical evaluation of different available guidelines for late-onset hypogonadism. ---
2020 Efficacy of testosterone replacement therapy on pain in hypogonadal men with chronic pain syndrome: A subanalysis of a prospective randomised controlled study in Japan (EARTH study). AMS, BP, IPSS, PSA, TRT
2020 Late-onset hypogonadism and lifestyle-related metabolic disorders. HPT, TRT
2020 Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy. eNOS, TOM, TRT
2020 Lipid accumulation product and late-onset hypogonadism in middle-aged and elderly men: results from a cross-sectional study in China. LAP, TG, WC
2020 Optimizing Aging Male Symptom Questionnaire Through Genetic Algorithms Based Machine Learning Techniques. AMS, GA
2020 Relationship between Hypogonadal Symptoms, Sexual Dysfunction and Chronic Prostatitis in Middle-Aged Men by Self-Reported Questionnaires, even without Biochemical Testosterone Deficiency. ADAM, ED, IIEF-5, NIH-CPSI, PE, PEDT
2020 Testosterone replacement therapy. IM, PKs, RCTs, TRT
2019 An analysis of online content related to testosterone supplementation. TRT
10  2019 Androgen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications. ED, NO, PDE5i, TRT
11  2019 Correlation between serum P450arom and sex hormones in males with late-onset hypogonadism: a pilot study. ADAM, AMS, BMI, TSI
12  2019 Effect of Korean Herbal Formula (Modified Ojayeonjonghwan) on Androgen Receptor Expression in an Aging Rat Model of Late Onset Hypogonadism. AR
13  2019 Effects of transdermal administration of testosterone gel on the urinary steroid profile in hypogonadal men: Implications in antidoping analysis. ABP, EI, MRM, T-gel
14  2019 Efficacy of combined treatment of intramuscular testosterone injection and testosterone ointment application for late-onset hypogonadism: an open-labeled, randomized, crossover study. CT, GL, IMIM, TRT
15  2019 Investigating the basis of sexual dysfunction during late-onset hypogonadism. ---
16  2019 Late-onset hypogonadism (LOH), masculinity and relationship and sexual satisfaction: are sexual symptoms of LOH mediators of traditional masculinity on relationship and sexual satisfaction? ---
17  2019 Late-onset hypogonadism: a concept comes of age. EMAS
18  2019 Synthesis and biological evaluation of methylpyrimidine-fused tricyclic diterpene analogs as novel oral anti-late-onset hypogonadism agents. TRT
19  2019 The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism. AUA, EAA, EAU, ESE, ISSAM, TRT, TT
20  2018 A randomized, controlled study of treatment with ojayeonjonghwan for patients with late onset hypogonadism. ---
21  2018 Androgen Receptor CAG Repeat Length as a Risk Factor of Late-Onset Hypogonadism in a Korean Male Population. AMS, AR
22  2018 Autophagy regulates testosterone synthesis by facilitating cholesterol uptake in Leydig cells. NHERF2, SR-BI
23  2018 Clinical relevance of low androgen to gastroesophageal reflux symptoms. AMS, FT, SDS
24  2018 Efficacy of Testosterone Treatment in Hemodialysis Patients as Assessed by Aging Males' Symptoms Scores: A Pilot Study. AMS
25  2018 Establishing normal values of total testosterone in adult healthy men by the use of four immunometric methods and liquid chromatography-mass spectrometry. BMI, IMAs, RRs
26  2018 Hypothalamic Response to Kisspeptin-54 and Pituitary Response to Gonadotropin-Releasing Hormone Are Preserved in Healthy Older Men. FSH, GnRH, LH
27  2018 Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism. AMS, BMI, IIEF-5, IPSS, LUTS, PSA, TRT
28  2018 In vitro and in vivo androgen regulation of Dendropanax morbiferus leaf extract on late-onset hypogonadism. 3beta-HSD, DME
29  2018 Lycium chinense Mill improves hypogonadism via anti-oxidative stress and anti-apoptotic effect in old aged rat model. AR, SD
30  2018 Pharmacological management of late-onset hypogonadism. TTh
31  2018 Risk factors for late-onset hypogonadism. EMAS, FT, HDL, SBP, SHBG, TG, TT
32  2018 Secondary osteoporosis. Late-onset hypogonadisim in the aging male. ---
33  2018 Steroidogenic effects of Taraxacum officinale extract on the levels of steroidogenic enzymes in mouse Leydig cells. StAR, TOE, TSPO
34  2018 The efficacy and safety of short-acting testosterone ointment (Glowmin) for late-onset hypogonadism in accordance with testosterone circadian rhythm. AMS
35  2018 The SET protein promotes androgen production in testicular Leydig cells. CYP17a1, hCG, LH, LHR, StAR
36  2018 [Testosterone therapy: indications and risks]. ---
37  2017 A higher score on the Aging Males' Symptoms scale is associated with insulin resistance in middle-aged men. AMS, IDF
38  2017 Aging and sex hormones in males. ---
39  2017 Antioxidant and Antifibrotic Effect of a Herbal Formulation In Vitro and in the Experimental Andropause via Nrf2/HO-1 Signaling Pathway. ED, HO-1, Nrf2, SOD, TGF-beta
40  2017 Atherosclerosis is associated with erectile function and lower urinary tract symptoms, especially nocturia, in middle-aged men. AMS, baPWV, ED, EHS, IPSS, LUTS, QOL, SHIM
41  2017 Comparing calculated free testosterone with total testosterone for screening and diagnosing late-onset hypogonadism in aged males: A cross-sectional study. ADAM, AMS, cFT, SHBG
42  2017 Erectile dysfunction. ED, MetS
43  2017 Exercise improves the effects of testosterone replacement therapy and the durability of response after cessation of treatment: a pilot randomized controlled trial. ED, GAQ
44  2017 Late-onset hypogonadism. ---
45  2017 LOH (late-onset hypogonadism) syndrome. ---
46  2017 Multi-Institutional Survey of Medical Treatment for Late-Onset Hypogonadism in Japan. ---
47  2017 Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma. BMI, loRCC, mRCC, RCC, TT, TT
48  2017 Protective effect of calretinin on testicular Leydig cells via the inhibition of apoptosis. Cyto C, OD
49  2017 Testosterone level and endothelial dysfunction in patients with vasculogenic erectile dysfunction. BT, ED, EMPs, EPCs, TT
50  2017 Testosterone Replacement Therapy: Long-Term Safety and Efficacy. CV, HG
51  2017 Testosterone treatment and cardiovascular and venous thromboembolism risk: what is 'new'? CV, FDA, RCTs, VTE
52  2017 The biological and clinical advances of androgen receptor function in age-related diseases and cancer [Review]. AR
53  2017 [Oral Testosterone Undecanoate Capsules combined with Qilin Pills for late-onset hypogonadism in males]. AMS, QLP, TT, TUC
54  2017 [Testosterone replacement therapy and cardiovascular risk]. EMA, EMAS, FDA, TTh
55  2016 Applying machine learning techniques to the identification of late-onset hypogonadism in elderly men. ADAM, AMS, DT
56  2016 Association between late-onset hypogonadism syndrome plus metabolic syndrome and prostate cancer and its aggressiveness. BT, FT, PC, TT, TT/PSA
57  2016 Clomiphene citrate treatment for late onset hypogonadism: rise and fall. CC, TT
58  2016 DYSREGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS INCREASES CENTRAL BODY FAT ACCUMULATION IN MALES AFFECTED BY DIABETES MELLITUS AND LATE-ONSET HYPOGONADISM. AUC, DM, FH, HPA
59  2016 Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism. TU
60  2016 Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH Study). ART, IIEF-5, IPSS, SF-36, TG
61  2016 Effects of Saikokaryukotsuboreito on Spermatogenesis and Fertility in Aging Male Mice. ITT, ITT, SKRBT, SYCP3
62  2016 Effects of tadalafil treatment combined with physical activity in patients with low onset hypogonadism: results from a not-randomized single arm phase 2 study. PA, PDUE, TAD
63  2016 Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis. IPSS, LUTS, TRT
64  2016 Effects of velvet antler polypeptide on sexual behavior and testosterone synthesis in aging male mice. 3beta-HSD, ITT, P450scc, StAR, VAP
65  2016 EMAS position statement: Testosterone replacement therapy in the aging male‏. TRT
66  2016 How to define hypogonadism? Results from a population of men consulting for sexual dysfunction. AUC, cFT, ROC
67  2016 Identification of late-onset hypogonadism in middle-aged and elderly men from a community of China. AMS, cFT, SHBG, TT
68  2016 Influence of the hypothalamic-pituitary-adrenal axis dysregulation on the metabolic profile of patients affected by diabetes mellitus-associated late onset hypogonadism. AUC, DBP, DM, FH, HDL, HPA
69  2016 Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden? TRT
70  2016 Late-onset hypogonadism: the advantages of treatment with human chorionic gonadotropin rather than testosterone. hCG, HRT, PSA
71  2016 Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry. IIEF-15, OR, SIAMS
72  2016 Prevalence of Sexual Dysfunction and Associated Risk Factors in Middle-Aged and Elderly Korean Men in Primary Care. ED, PE, SD
73  2016 Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy. AMS, BP, HRQoL, MH, TRT
74  2016 RigiScan data under long-term testosterone therapy: improving long-term blood circulation of penile arteries, penile length and girth, erectile function, and nocturnal penile tumescence and duration. TT, TTh
75  2016 Testosterone replacement therapy and voiding dysfunction. BPH, LUTS, TRT
76  2016 Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism. AMS, HRQoL, IPSS, TRT, TT, TU
77  2016 The correlation between highly sensitive C-reactive protein levels and erectile function among men with late-onset hypogonadism. AMS, FT, hs-CRP, IPSS, SHIM
78  2016 The effect of testosterone on cardiometabolic risk factors in atorvastatin-treated men with late-onset hypogonadism. hs-CRP
79  2016 The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride. hs-CRP
80  2016 The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism. AI, PSA, TRT
81  2016 The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism. AMS, ROC, RT-PCR
82  2016 The reciprocal links between synaptophysin serum levels and the prevalence of metabolic syndrome according to selected low-grade inflammation indices and age-related androgen serum level changes in men. EMAS, LGSI, MS, SYP
83  2016 The rs5934505 single nucleotide polymorphism (SNP) is associated with low testosterone and late-onset hypogonadism, but the rs10822184 SNP is associated with overweight and obesity in a Chinese Han population: a case-control study. BMI, cFT, OR, ORs, SNP, SNPs
84  2016 [Diagnostic criteria for late-onset hypogonadism: A preliminary study]. ADAM, AMS, cFT, FTI, IIEF-5, TSI, TT
85  2015 A herbal medicine, saikokaryukotsuboreito, improves serum testosterone levels and affects sexual behavior in old male mice. SKRBT, StAR
86  2015 Alternatives to testosterone replacement: testosterone restoration. ---
87  2015 Andropause - state of the art 2015 and review of selected aspects. SHBG
88  2015 Can testosterone level be a good predictor of late-onset hypogonadism? LH
89  2015 Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men. ---
90  2015 Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism. AMS, ED, IPSS, SHBG, SHIM
91  2015 Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism. AR, EF, IIEF, IS, OF, OS, SD, TRT
92  2015 Inhibition of adipogenic differentiation of human SGBS preadipocytes by androgen-regulated microRNA miR-375. AdipoR2
93  2015 Is there a relationship between the severity of erectile dysfunction and the comorbidity profile in men with late onset hypogonadism? AMS, ED, SHBG, SHIM
94  2015 Late-onset hypogonadism among old and middle-aged males with prediabetes in Polish population. cFT, TT
95  2015 Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk. TRT
96  2015 Testosterone replacement alters the cell size in visceral fat but not in subcutaneous fat in hypogonadal aged male rats as a late-onset hypogonadism animal model. ICP, MAP
97  2015 The Effect of Metformin and Metformin-Testosterone Combination on Cardiometabolic Risk Factors in Men with Late-onset Hypogonadism and Impaired Glucose Tolerance. hs-CRP, IGT
98  2015 The prevalence of erectile dysfunction among subjects with late-onset hypogonadism: a population-based study in China. ADAM, AMS, cFT, ED, IIEF-5, TT
99  2015 [Effect and safety of testosterone undecanoate in the treatment of late-onset hypogonadism: a meta-analysis]. TU
100  2014 Androgen deficiency and metabolic syndrome in men. MetS, RTCs, TRT